Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions

Cyclin-dependent kinases (CDKs) are important regulatory enzymes in the normal physiological processes that drive cell-cycle transitions and regulate transcription. Virtually all cancers harbour genomic alterations that lead to the constitutive activation of CDKs, resulting in the proliferation of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Juric, Viktorija, Murphy, Brona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094053/
https://www.ncbi.nlm.nih.gov/pubmed/35582046
http://dx.doi.org/10.20517/cdr.2019.105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094053/
https://www.ncbi.nlm.nih.gov/pubmed/35582046
http://dx.doi.org/10.20517/cdr.2019.105

Ejemplares similares